Document:

Exhibit 4.3

 

Consent of Independent Registered
Public Accounting Firm

We have issued our
report dated September 9, 2020, with respect to the financial statement of SmartTrust 478 contained in Amendment No. 4 to the Registration
Statement on Form S-6 (File No. 333-236435) and related Prospectus. We consent to the use of the aforementioned report in the Registration
Statement and Prospectus, and to the use of our name as it appears under the caption “Independent Registered Public Accounting
Firm”.

 

/s/ Grant
Thornton LLP

 

Chicago, Illinois

September 9, 2020EX-10.1

 Exhibit 10.1 

September 8, 2020 
 Peter Pfreundschuh 

Dear Peter: 
 This letter sets forth the
substance of the separation agreement (the “Agreement”) that UroGen Pharma, Inc. (the “Company”) is offering to you to aid in your employment transition, and in accordance with the Executive Employment Agreement
between the Company and you, dated July 31, 2018 (the “Employment Agreement”). 

1.    SEPARATION. Your employment termination date will be
October 15, 2020 (the “Separation Date”). As of the Separation Date, you will also be deemed to have resigned from any other position or office you hold with the Company, UroGen Pharma, Ltd. (“Parent”), and any
of their affiliates. 
 2.    ACCRUED SALARY AND
PAID TIME OFF. On the next payroll date after the Separation Date, the Company will pay you all accrued salary, and all accrued and unused paid time off earned through the
Separation Date, subject to standard payroll deductions and withholdings. You are entitled to these payments regardless of whether or not you sign this Agreement. 

3.    SEVERANCE BENEFITS. Although the Company
has no obligation to do so, if you: (i) sign and return this Agreement to the Company on or within twenty-one (21) days after the Separation Date; (ii) allow the releases contained herein to
become effective; (iii) remain reasonably available after your Separation Date to answer any questions from the Company regarding your previous job duties; and (iv) comply with this Agreement and all of your legal and contractual
obligations to the Company, then the Company will provide you with the following severance benefits (the “Severance Benefits”): 

(a)    Severance Payment. The Company will pay you, as severance, an amount equivalent to six
(6) months of your current base salary (in the gross amount of $224,347), subject to standard payroll deductions and withholdings (the “Severance Payment”). The Severance Payment will be paid to you as a continuation on the
Company’s regular payroll, beginning within ten (10) days after the Effective Date (as defined below). 

(b)    Pro-Rata Bonus. You will be eligible to receive the
equivalent of a nine (9) month pro rata portion of your current potential annual 50% target bonus for calendar year 2020 (the “Pro Rata Bonus”). The Pro Rata Bonus shall be paid only to the extent earned based on actual Company
performance, with any individual performance component deemed achieved (for example, if the Company’s corporate goals for 2020 are deemed achieved at the 110% level, your Pro Rata Bonus will be $185,086.27 (1.1*9/12*.5*$448,694)). The Pro Rata
Bonus will be paid to you, subject to standard payroll deductions and withholdings, on the date in the year following your termination on which bonuses are paid to other senior executives of the Company, but in no event later than March 15 of
such year. 

 Peter Pfreundschuh 

 Page
 2
 
  

 (c)     Equity Acceleration. As summarized in Exhibit
A to this Agreement, you were previously granted a total of 23,500 shares of restricted stock of Parent (collectively, the “RS”) and options to purchase a total of 80,000 ordinary shares of the Parent (collectively, the
“Option”). Under the terms of the governing plan documents and Option and RS agreements, all vesting will cease as of the Separation Date. As an additional Severance Benefit, the vesting of each RS and Option grant shall accelerate
such that the amount of each RS and Option that would have otherwise become vested as of April 15, 2021, shall become issuable or exercisable, respectively, as of the Separation Date. The vested amounts of each such RS and Option grant are set
forth in Exhibit A, which you acknowledge and agree correctly sets forth all of your equity interests in the Company, Parent, or any affiliate. Also as an additional Severance Benefit, the post termination exercise period for your vested
Options as of the Separation Date shall be extended to 180 days following the Separation Date. 

(d)    Health Insurance. To the extent provided by the federal COBRA law or, if applicable, state insurance
laws, and by the Company’s current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense. Later, you may be able to convert to an individual policy through the provider of the
Company’s health insurance, if you wish. If you timely elect continued coverage under COBRA, the Company will pay for the COBRA premiums to continue your health insurance coverage (including coverage for eligible dependents, if applicable)
(“COBRA Premiums”) through the period (the “COBRA Premium Period”) starting on the Separation Date and ending on the earliest to occur of: (i) the six (6) month anniversary of the Separation Date;
(ii) the date you become eligible for group health insurance coverage through a new employer; or (iii) the date you cease to be eligible for COBRA continuation coverage for any reason. You must timely pay your premiums, and then provide
the Company with proof of same to obtain reimbursement for your COBRA premiums under this Section 3(d). In the event you become covered under another employer’s group health plan or otherwise cease to be eligible for COBRA during the COBRA
Premium Period, you must immediately notify the Company of such event. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot pay the COBRA Premiums without a substantial risk of violating applicable law
(including, without limitation, Section 2716 of the Public Health Service Act), the Company instead shall pay you, on the first day of each calendar month, a fully taxable cash payment equal to the applicable COBRA premiums for that month for
the remainder of the COBRA Premium Period, which you may (but are not obligated to) use toward the cost of COBRA premiums. 

4.    OTHER COMPENSATION OR BENEFITS. You
acknowledge and agree that the Severance Benefits represent full and complete satisfaction of the benefits you may be eligible to receive pursuant to the Employment Agreement, any prior employment agreement or offer letter, or otherwise. You
acknowledge that, except for your base salary and as expressly provided in this Agreement, you have not earned and will not receive from the Company any additional compensation (including bonus, incentive compensation, or equity), severance, or
benefits before or after the Separation Date, with the exception of any vested right you may have under the express terms of a written ERISA-qualified benefit plan (e.g., 401(k) account). 

 Peter Pfreundschuh 

 Page
 3
 
  

 5.    EXPENSE REIMBURSEMENTS.
You agree that, within thirty (30) days after the Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek
reimbursement. The Company will reimburse you for these expenses pursuant to its regular business practice. 

6.    RETURN OF COMPANY PROPERTY. On or within five
(5) days after the Separation Date, you will return to the Company all Company documents (and all copies thereof) and other Company property in your possession or control, including, but not limited to, Company files, notes, drawings, records,
business plans and forecasts, contact information, financial information, specifications, training materials, computer-recorded information, tangible property including, but not limited to, computers, credit cards, entry cards, identification badges
and keys; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof). You represent that you have made a diligent search to locate any such documents, property and
information within the required timeframe. In addition, if you have used any personally owned computer, server, e-mail system, mobile phone, portable electronic device (e.g., smartphone, iPad or the like),
(collectively, “Personal Systems”) to receive, store, prepare or transmit any Company confidential or proprietary data, materials or information, then within five (5) days after the Separation Date, you will permanently delete
and expunge all such Company confidential or proprietary information from such Personal Systems without retaining any copy or reproduction in any form (in whole or in part). The Company shall permit you to transfer from your work computer to a
personal storage mechanism prior to the Separation Date your personal email folder, personal photos, music and video files, personal electronic files, and personal contact and calendar database, subject to reasonable review and approval of such
transfers by the Company. You agree that, after the applicable timeframes noted above, you will neither use nor possess Company property. Your timely compliance with this paragraph is a condition precedent to your receipt of the Severance
Benefits described above. 
 7.    CONFIDENTIALITY. Notwithstanding any provision in
this Agreement or the Confidentiality Agreement (defined below) to the contrary, nothing herein shall prevent you from disclosing the fact or terms of this Agreement as part of any government investigation, or prohibit you from filing a charge,
complaint, or report with, or otherwise communicating with, providing information to, or cooperating, or participating with any investigation or proceeding by or before the Equal Employment Opportunity Commission, the United States Department of
Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, or any other federal, state or local government agency or commission. 

8.    NO ADMISSIONS. You understand and agree that the promises and
payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission. 

 Peter Pfreundschuh 

 Page
 4
 
  

 9.    RELEASE OF CLAIMS.

 (a)    General Release. In exchange for the consideration provided to you under this Agreement to
which you would not otherwise be entitled, you hereby generally and completely release the Company, Parent, and each of its and their affiliated, related, parent and subsidiary entities, and each of its and their current and former directors,
officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns (collectively, the “Released Parties”) from any and all claims, liabilities and obligations, both known and
unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to or on the date you sign this Agreement (collectively, the “Released Claims”). 

(b)    Scope of Release. The Released Claims include, but are not limited to: (i) all claims arising
out of or in any way related to your employment with the Company, or the termination of that employment; (ii) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation, expense
reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good
faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for
discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of
1967 (as amended) (the “ADEA”), the New York State Human Rights Law, the New York Executive Law, the New York Civil Practice Law and Rules, the New York Judiciary Law, the New York Corrections Law, the New York Labor Law, the New
York Civil Rights Law, the New York Administrative Code, the New York City Administrative Code, the New York City Human Rights Law, the New York Hours of Labor Law, the New York Wage Payment Law, the New York Minimum Wage Act, the New York
Whistleblower Law, and the New York Off-Duty Conduct Lawful Activities Discrimination Law. 

(c)    Excluded Claims. Notwithstanding the foregoing, the following are not included in the Released Claims
(the “Excluded Claims”): (i) any rights or claims for indemnification you may have pursuant to any written indemnification agreement with the Company to which you are a party or under applicable law; (ii) any rights which
are not waivable as a matter of law (such as claims for unemployment benefits or workers compensation); and (iii) any claims for breach of this Agreement. In addition, nothing in this Agreement prevents you from filing, cooperating with, or
participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, the New York State Division of Human Rights, the New York City Commission on Human Rights, or any other government agency, except that you
acknowledge and agree that you hereby waive your right to any monetary benefits in connection with any such claim, charge or proceeding. Additionally, while this Agreement does not limit your right to receive an award for information provided to the
Securities and Exchange Commission, you are otherwise waiving, to the fullest extent permitted by law, any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this
Agreement. 
 (d)     ADEA Waiver. You acknowledge that you are knowingly and voluntarily waiving and
releasing any rights you may have under the ADEA, and that the consideration given for the waiver and release in this Section is in addition to anything of value to which you are already 

 Peter Pfreundschuh 

 Page
 5
 
  

 
entitled. You further acknowledge that you have been advised, as required by the ADEA, that: (i) your waiver and release do not apply to any rights or claims that may arise after the date
that you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have twenty-one (21) days to
consider this Agreement (although you may choose voluntarily to sign it earlier); (iv) you have seven (7) days following the date you sign this Agreement to revoke it (by providing written notice of your revocation to me); and (v) this
Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it (the “Effective Date”).

 10.    REPRESENTATIONS. You hereby represent that you have been paid all compensation
owed and for all hours worked, have received all the leave and leave benefits and protections for which you are eligible pursuant to the Family and Medical Leave Act or otherwise, and have not suffered any on-the-job injury for which you have not already filed a workers’ compensation claim. You also acknowledge and agree that you do not possess any claim or allegation, either asserted or otherwise,
involving harassment or discrimination, that may be subject to or covered under N.Y. C.P.L.R. § 5003-b and N.Y. General Obligations Law § 5-336. 

11.    CONTINUING OBLIGATIONS;
NON-DISPARAGEMENT. You acknowledge that you remain bound by the Employee Proprietary Information, Inventions, Non-Solicitations and Non-Competition Agreement (the “Confidentiality Agreement”) between you and the Company, attached hereto as Exhibit B, and agree to abide by those continuing obligations. You further
acknowledge and agree that Section 13 of the Employment Agreement (Dispute Resolution) shall survive the termination of your employment, along with any other provisions of the Employment Agreement that by their terms are designed to survive the
termination of your employment. You also agree not to disparage the Company, its officers, directors, employees, shareholders, and agents, in any manner likely to be harmful to its or their business, business reputation, or personal reputation, and
the Company agrees to instruct its directors and officers not to disparage you in any manner likely to be harmful to your business or personal reputation; provided that any party may respond accurately and fully to any question, inquiry or request
for information when required by legal process. 
 12.    MISCELLANEOUS. This Agreement,
including its exhibits, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or
oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in writing signed by both you and a duly authorized officer of the
Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. The Company may freely assign this
Agreement, without your prior written consent. You may not assign any of your duties hereunder and you may not assign any of your rights hereunder without the written consent of the Company. If any provision of this Agreement is determined to be
invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable. This Agreement will be deemed to have

 Peter Pfreundschuh 

 Page
 6
 
  

 
been entered into and will be construed and enforced in accordance with the laws of the State of New York without regard to conflict of laws principles. Any ambiguity in this Agreement shall not
be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and facsimile signatures
and signatures transmitted by PDF will suffice as original signatures. 
 If this Agreement is acceptable to you, please sign below and
return the original to me. You have twenty-one (21) calendar days to decide whether you would like to accept this Agreement, and the Company’s offer contained herein will automatically expire if you
do not sign and return it within this timeframe. 
 We wish you the best in your future endeavors. 

Sincerely, 
  

			
	UROGEN PHARMA, INC.
		
	By:	 	 /s/ Liz Barrett

		 	Liz Barrett
		 	President and Chief Executive Officer

 EXHIBIT A – Equity Summary 

EXHIBIT B – Employee Proprietary Information, Inventions, Non-Solicitations and Non-Competition Agreement 
 I HAVE READ, UNDERSTAND
AND AGREE FULLY TO THE FOREGOING AGREEMENT: 
  

			
		
		 	 /s/ Peter Pfreundschuh

		 	Peter Pfreundschuh
		
		 	 September 8, 2020

		 	Date

 EXHIBIT A 

EQUITY SUMMARY 

Restricted Stock Awards 
  

									
	 Date of

Grant
	  	Total Shares
Granted	  	Total Shares
Vested as of the
Separation Date	  	Unvested Shares
Subject to Accelerated
Vesting	  	Total Vested Shares
	 8/20/2018
	  	12,500	  	8,333	  	2,083	  	10,416
	 1/26/2019
	  	5,000	  	2,500	  	833	  	3,333
	 1/31/2020
	  	6,000	  	0	  	2,000	  	2,000

 Stock Option Grants 
  

									
	 Date of

Grant
	  	Total Shares
Granted	  	Total Shares
Vested as of the
Separation Date	  	Unvested Shares
Subject to
Accelerated
Vesting	  	Total Vested
Shares
	 8/20/2018
	  	50,000	  	33,333	  	8,333	  	41,666
	 1/26/2019
	  	15,000	  	7,500	  	2,500	  	10,000
	 1/31/2020
	  	15,000	  	0	  	5,000	  	5,000

 Peter Pfreundschuh 

Page 2 
  

 EXHIBIT B 

EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, NON-SOLICITATIONS AND NON- 
 EMPLOYEE
PROPRIETARY INFORMATION, INVENTIONS, NON-SOLICITATION 

AND NON-COMPETITION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]